VISICOL Side Effects

7009422-6 | Device Difficult To Use, Hyperphosphataemia, Hypoaesthesia, Hypocalcaemia, Optic Neuritis, Tetany, Vision Blurred, Visual Impairment
on Sep 17, 2010 Female patient from JAPAN , 65 years of age, was diagnosed with bowel preparation and was treated with Visicol (View Usage). Patient experienced the following unwanted or unexpected effects: device difficult to use, hyperphosphataemia, hypoaesthesia, hypocalcaemia, optic neuritis, tetany, vision blurred, visual impairment. Visicol dosage: (50 Gm), Oral. During the same period patient was treated with LACTULOSE (View Lactulose Review and Lactulose Label ), BROMHEXINE HYDROCHLORIDE (View Bromhexine Hydrochloride Review and Bromhexine Hydrochloride Label ), TEPRENONE (View Teprenone Review and Teprenone Label ), SERRAPEPTASE (View Serrapeptase Review and Serrapeptase Label ), THEOPHYLLINE (View Theophylline Review and Theophylline Label ), SENNOSIDE (View Sennoside Review and Sennoside Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), OXATOMIDE (View Oxatomide Review and Oxatomide Label ). Patient was hospitalized and became disabled.

7009341-5 | Asthenia, Blood Potassium Decreased, Hypoaesthesia
Patient was taking Visicol (View Usage). Patient had the following side effects: asthenia, blood potassium decreased, hypoaesthesia on Sep 17, 2010 from JAPAN Additional patient health information: Female patient , 22 years of age, was diagnosed with endoscopy large bowel and. Visicol dosage: 50 Gm,oral. During the same period patient was treated with MAGNESIUM CITRATE (View Magnesium Citrate Review and Magnesium Citrate Label ). Patient was hospitalized.

6967474-3 | Demyelination, Hyperphosphataemia, Hypoaesthesia, Hypocalcaemia, No Therapeutic Response, Optic Nerve Disorder, Optic Neuritis, Procedural Complication, Tetany
Adverse event was reported on Aug 30, 2010 by a Female patient taking Visicol (View Usage) (Dosage: 50 Gm, Oral) was diagnosed with bowel preparation and. Location: JAPAN , 65 years of age, After Visicol was administered, patient had the following side effects: demyelination, hyperphosphataemia, hypoaesthesia, hypocalcaemia, no therapeutic response, optic nerve disorder, optic neuritis, procedural complication, tetany. During the same period patient was treated with LACTULOSE (View Lactulose Review and Lactulose Label ), BROMHEXINE HYDROCHLORIDE (View Bromhexine Hydrochloride Review and Bromhexine Hydrochloride Label ), TEPRENONE (View Teprenone Review and Teprenone Label ), SERRAPEPTASE (View Serrapeptase Review and Serrapeptase Label ), THEOPHYLLINE (View Theophylline Review and Theophylline Label ), SENNOSIDE (View Sennoside Review and Sennoside Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), OXATOMIDE (View Oxatomide Review and Oxatomide Label ). Patient was hospitalized and became disabled.

6939494-6 | Compression Fracture, Convulsion, Fall, Hyperphosphataemia, Lumbar Vertebral Fracture, Oxygen Saturation Decreased
on Aug 19, 2010 Male patient from JAPAN , 69 years of age, was diagnosed with bowel preparation and was treated with Visicol (View Usage). Patient experienced the following unwanted or unexpected effects: compression fracture, convulsion, fall (What is fall?), hyperphosphataemia, lumbar vertebral fracture, oxygen saturation decreased. Visicol dosage: 50 Gm Oral. Patient was hospitalized.


6930297-5 | Haemodialysis, Hyperphosphataemia, Hypocalcaemia, Optic Neuritis, Tetany
on Aug 11, 2010 Female patient from JAPAN , 65 years of age, was diagnosed with bowel preparation and was treated with Visicol (View Usage). Patient had the following side effects: haemodialysis, hyperphosphataemia, hypocalcaemia, optic neuritis, tetany. Visicol dosage: Oral. Patient was hospitalized.

6930296-3 | Fall, Hyperphosphataemia, Loss Of Consciousness, Spinal Compression Fracture
Patient was taking Visicol (View Usage). After Visicol was administered, patient had the following side effects: fall (What is fall?), hyperphosphataemia, loss of consciousness, spinal compression fracture on Aug 11, 2010 from JAPAN Additional patient health information: Male patient , 69 years of age, was diagnosed with bowel preparation and. Visicol dosage: (50 Gm), Oral. Patient was hospitalized.

6894352-0 | Blood Creatinine Increased, Blood Urea Increased, Decreased Appetite, Fatigue, Hypophagia, Malaise, Nausea, Nephrocalcinosis, Weight Decreased
Adverse event was reported on Jul 19, 2010 by a Female patient taking Visicol (View Usage) (Dosage: (28 Tablets), Oral) was diagnosed with colonoscopy (What is colonoscopy?) and. Location: UNITED STATES , 59 years of age, weighting 118.2 lb, Patient experienced the following unwanted or unexpected effects: blood creatinine increased, blood urea increased, decreased appetite, fatigue, hypophagia, malaise, nausea (What is nausea?), nephrocalcinosis, weight decreased. During the same period patient was treated with LOTREL (View Lotrel Review and Lotrel Label ), CELEBREX (View Celebrex Review and Celebrex Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), DETROL LA (View Detrol La Review and Detrol La Label ), PREMPRO (View Prempro Review and Prempro Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ALEVE (CAPLET) (View Aleve (caplet) Review and Aleve (caplet) Label ).

6847539-7 | Acute Phosphate Nephropathy, Anaemia, Renal Failure Acute, Renal Failure Chronic
on Jul 12, 2010 Female patient from UNITED STATES , 74 years of age, was diagnosed with colonoscopy (What is colonoscopy?) and was treated with Visicol (View Usage). Patient had the following side effects: acute phosphate nephropathy, anaemia, renal failure acute, renal failure chronic. Visicol dosage: Oral. During the same period patient was treated with HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), DIOVAN (View Diovan Review and Diovan Label ), ALEVE (CAPLET) (View Aleve (caplet) Review and Aleve (caplet) Label ), PROTONIX (View Protonix Review and Protonix Label ), LIPITOR (View Lipitor Review and Lipitor Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6763463-2 | Azotaemia, Blood Pressure Increased, Dyspnoea, Haemodialysis, Hypocalcaemia, Nausea, Renal Failure Acute
on Jun 04, 2010 Female patient from JAPAN , 67 years of age, was diagnosed with bowel preparation and was treated with Visicol (View Usage). After Visicol was administered, patient had the following side effects: azotaemia, blood pressure increased, dyspnoea, haemodialysis, hypocalcaemia, nausea (What is nausea?), renal failure acute. Visicol dosage: (50 Gm),oral. During the same period patient was treated with VALSARTAN AND HYDROCHLOROTHIAZIDE (View Valsartan And Hydrochlorothiazide Review and Valsartan And Hydrochlorothiazide Label ), CILNIDIPINE (View Cilnidipine Review and Cilnidipine Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), MELOXICAM (View Meloxicam Review and Meloxicam Label ), ALFACALCIDOL (View Alfacalcidol Review and Alfacalcidol Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ). Patient was hospitalized.

6754975-6 | Abdominal Distension, Blood Pressure Increased, Dyspnoea, Fluid Retention, Haemodialysis, Hypocalcaemia, Nausea, Renal Failure Acute
Patient was taking Visicol (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, blood pressure increased, dyspnoea, fluid retention, haemodialysis, hypocalcaemia, nausea (What is nausea?), renal failure acute on May 25, 2010 from JAPAN Additional patient health information: Female patient , 67 years of age, was diagnosed with bowel preparation and. Visicol dosage: 50 Gm, Oral. During the same period patient was treated with VALSARTAN AND HYDROCHLOROTHIAZIDE (View Valsartan And Hydrochlorothiazide Review and Valsartan And Hydrochlorothiazide Label ), CILNIDIPINE (View Cilnidipine Review and Cilnidipine Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), MELOXICAM (View Meloxicam Review and Meloxicam Label ), ALFACALCIDOL (View Alfacalcidol Review and Alfacalcidol Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ). Patient was hospitalized.

6738423-8 | Abdominal Distension, Apparent Life Threatening Event, Aptyalism, Blood Phosphorus Increased, Catheter Culture Positive, Decreased Appetite, Enterococcal Sepsis, Fatigue
Adverse event was reported on May 19, 2010 by a Female patient taking Visicol (View Usage) (Dosage: (50 Gm), Oral) was diagnosed with bowel preparation and. Location: JAPAN , 76 years of age, Patient had the following side effects: abdominal distension, apparent life threatening event, aptyalism, blood phosphorus increased, catheter culture positive, decreased appetite, enterococcal sepsis, fatigue. During the same period patient was treated with NICORANDIL (View Nicorandil Review and Nicorandil Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), ROSUVASTATIN CALCIUM (View Rosuvastatin Calcium Review and Rosuvastatin Calcium Label ), BIFIDOBACTERIUM (View Bifidobacterium Review and Bifidobacterium Label ). Patient was hospitalized.

6686224-1 | Abdominal Distension, Aptyalism, Blood Phosphorus Increased, Decreased Appetite, Device Related Infection, Enterococcal Infection, Enterococcal Sepsis, Fatigue
on Apr 12, 2010 Female patient from JAPAN , 76 years of age, was diagnosed with bowel preparation and was treated with Visicol (View Usage). After Visicol was administered, patient had the following side effects: abdominal distension, aptyalism, blood phosphorus increased, decreased appetite, device related infection, enterococcal infection, enterococcal sepsis, fatigue. Visicol dosage: 50 Gm, Oral. During the same period patient was treated with NICORANDIL (View Nicorandil Review and Nicorandil Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), ROSUVASTATIN CALCIUM (View Rosuvastatin Calcium Review and Rosuvastatin Calcium Label ), BIFIDOBACTERIUM (View Bifidobacterium Review and Bifidobacterium Label ). Patient was hospitalized.

6668932-1 | Abdominal Distension, Aptyalism, Blood Phosphorus Increased, Decreased Appetite, Device Related Infection, Enterococcal Infection, Fatigue, Haemodialysis
on Mar 30, 2010 Female patient from JAPAN , 76 years of age, was diagnosed with bowel preparation and was treated with Visicol (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, aptyalism, blood phosphorus increased, decreased appetite, device related infection, enterococcal infection, fatigue, haemodialysis. Visicol dosage: (50 Gm), Oral. During the same period patient was treated with NICORANDIL (View Nicorandil Review and Nicorandil Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), ROSUVASTATIN CALCIUM (View Rosuvastatin Calcium Review and Rosuvastatin Calcium Label ), BIFIDOBACTERIUM (View Bifidobacterium Review and Bifidobacterium Label ). Patient was hospitalized.

6667298-0 | Dialysis, Renal Failure Acute
Patient was taking Visicol (View Usage). Patient had the following side effects: dialysis (What is dialysis?), renal failure acute on Apr 01, 2010 from UNITED STATES Additional patient health information: Female patient , 49 years of age, weighting 160.0 lb, was diagnosed with colonoscopy (What is colonoscopy?) and. Visicol dosage: 20 Tabs Night Before Colonoscopy:20 Tabs Day Of Colonoscopy 3 Every 15 Minutes Po. Patient was hospitalized and became disabled.

6662515-5 | Acute Prerenal Failure, Ascites, Brain Natriuretic Peptide Increased, Diarrhoea, Headache, Hypokalaemia, Malaise, Palpitations
Adverse event was reported on Mar 24, 2010 by a Female patient taking Visicol (View Usage) (Dosage: Oral) was diagnosed with bowel preparation and. Location: JAPAN , 62 years of age, After Visicol was administered, patient had the following side effects: acute prerenal failure, ascites, brain natriuretic peptide increased, diarrhoea, headache (What is headache?), hypokalaemia, malaise, palpitations. During the same period patient was treated with DIAZEPAM (View Diazepam Review and Diazepam Label ), OLMESARTAN MEDOXIMIL (View Olmesartan Medoximil Review and Olmesartan Medoximil Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), MOSAPRIDE CITRATE (View Mosapride Citrate Review and Mosapride Citrate Label ), TRIMEBUTINE (View Trimebutine Review and Trimebutine Label ), EPERISONE (View Eperisone Review and Eperisone Label ), MELOXICAM (View Meloxicam Review and Meloxicam Label ).

6644529-4 | Acute Prerenal Failure, Ascites, Brain Natriuretic Peptide Increased, Diarrhoea, Headache, Hypokalaemia, Malaise, Nausea, Oedema Peripheral
on Mar 12, 2010 Female patient from JAPAN , 62 years of age, was diagnosed with bowel preparation and was treated with Visicol (View Usage). Patient experienced the following unwanted or unexpected effects: acute prerenal failure, ascites, brain natriuretic peptide increased, diarrhoea, headache (What is headache?), hypokalaemia, malaise, nausea (What is nausea?), oedema peripheral. Visicol dosage: Oral. During the same period patient was treated with DIAZEPAM (View Diazepam Review and Diazepam Label ), OLMESARTAN MEDOXIMIL (View Olmesartan Medoximil Review and Olmesartan Medoximil Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ... (View ... Review and ... Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), MOSAPRIDE CITRATE (View Mosapride Citrate Review and Mosapride Citrate Label ), TRIMEBUTINE (View Trimebutine Review and Trimebutine Label ), EPERISONE (View Eperisone Review and Eperisone Label ).

6626855-8 | Blood Creatine Phosphokinase Increased, Disorientation, Hypochloraemia, Hypokalaemia, Hyponatraemia, Muscular Weakness, Vomiting
on Mar 05, 2010 Male patient from JAPAN , 67 years of age, was diagnosed with colonoscopy (What is colonoscopy?) and was treated with Visicol (View Usage). Patient had the following side effects: blood creatine phosphokinase increased, disorientation, hypochloraemia, hypokalaemia, hyponatraemia, muscular weakness, vomiting. Visicol dosage: (50 Gm), Oral. During the same period patient was treated with SODIUM PICOSULFATE (SOLUTION) (View Sodium Picosulfate (solution) Review and Sodium Picosulfate (solution) Label ), SENNOSIDE (View Sennoside Review and Sennoside Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ). Patient was hospitalized.

6615260-6 | Dialysis, Dyspnoea, Renal Failure Acute, Weight Increased
Patient was taking Visicol (View Usage). After Visicol was administered, patient had the following side effects: dialysis (What is dialysis?), dyspnoea, renal failure acute, weight increased on Feb 24, 2010 from JAPAN Additional patient health information: Male patient , 70 years of age, was diagnosed with colonoscopy (What is colonoscopy?) and. Visicol dosage: (50 Gm), Oral. During the same period patient was treated with PROPOFOL ((2 Ml), Intravenous) (View Propofol Review and Propofol Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), PETHIDINE HYDROCHLORIDE (View Pethidine Hydrochloride Review and Pethidine Hydrochloride Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), CARBAZOCHROME SODIUM SULFONATE (View Carbazochrome Sodium Sulfonate Review and Carbazochrome Sodium Sulfonate Label ), TRANEXAMIC ACID (View Tranexamic Acid Review and Tranexamic Acid Label ), GLYCYRRHIZIC ACID METHIONINE COMBINATION (View Glycyrrhizic Acid-methionine Combination Review and Glycyrrhizic Acid-methionine Combination Label ). Patient was hospitalized.

6613820-X | Anaemia, Dyspnoea, Face Oedema, Faeces Discoloured, Nephrocalcinosis, Nephropathy, Renal Failure Acute
Adverse event was reported on Feb 22, 2010 by a Male patient taking Visicol (View Usage) (Dosage: (50 Gm),oral) was diagnosed with bowel preparation and. Location: JAPAN , 77 years of age, Patient experienced the following unwanted or unexpected effects: anaemia, dyspnoea, face oedema, faeces discoloured, nephrocalcinosis, nephropathy, renal failure acute. During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), VALSARTAN (View Valsartan Review and Valsartan Label ), BICALUTAMIDE (View Bicalutamide Review and Bicalutamide Label ), TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), LEUPRORELIN ACETATE (View Leuprorelin Acetate Review and Leuprorelin Acetate Label ). Patient was hospitalized.

6613381-5 | Disorientation, Malaise, Muscular Weakness, Vomiting
on Feb 24, 2010 Male patient from JAPAN , 67 years of age, was diagnosed with bowel preparation and was treated with Visicol (View Usage). Patient had the following side effects: disorientation, malaise, muscular weakness, vomiting. Visicol dosage: (50 Gm),oral. During the same period patient was treated with SODIUM PICOSULFATE (SOLUTION) (View Sodium Picosulfate (solution) Review and Sodium Picosulfate (solution) Label ), SENNOSIDE (View Sennoside Review and Sennoside Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ). Patient was hospitalized.

6588169-4 | Blood Chloride Decreased, Blood Sodium Decreased, Disorientation, Muscular Weakness, Vomiting
on Feb 05, 2010 Male patient from JAPAN , 67 years of age, was diagnosed with colonoscopy (What is colonoscopy?) and was treated with Visicol (View Usage). After Visicol was administered, patient had the following side effects: blood chloride decreased, blood sodium decreased, disorientation, muscular weakness, vomiting. Visicol dosage: (50 Gm), Oral. During the same period patient was treated with SODIUM PICOSULFATE (SOLUTION) (View Sodium Picosulfate (solution) Review and Sodium Picosulfate (solution) Label ), SENNOSIDE (View Sennoside Review and Sennoside Label ), METOCLOPRAMIDE HYDROCHLORIDE (View Metoclopramide Hydrochloride Review and Metoclopramide Hydrochloride Label ). Patient was hospitalized.

6588150-5 | Acute Prerenal Failure, Diarrhoea, Headache, Nausea, Pelvic Fluid Collection
Patient was taking Visicol (View Usage). Patient experienced the following unwanted or unexpected effects: acute prerenal failure, diarrhoea, headache (What is headache?), nausea (What is nausea?), pelvic fluid collection on Feb 05, 2010 from JAPAN Additional patient health information: Female patient , 62 years of age, was diagnosed with bowel preparation and. Visicol dosage: Oral. During the same period patient was treated with DIAZEPAM (View Diazepam Review and Diazepam Label ), OLMESARTAN MEDOXOMIL (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), MOSAPRIDE CITRATE (View Mosapride Citrate Review and Mosapride Citrate Label ), TRIMEBUTINE (View Trimebutine Review and Trimebutine Label ), EPERISONE (View Eperisone Review and Eperisone Label ).

6571301-6 | Altered State Of Consciousness, Hyponatraemia
Adverse event was reported on Jan 22, 2010 by a Male patient taking Visicol (View Usage) (Dosage: (50 Gm),oral) was diagnosed with colonoscopy (What is colonoscopy?) and. Location: JAPAN , 67 years of age, Patient had the following side effects: altered state of consciousness, hyponatraemia. Patient was hospitalized.

6556523-2 | Acute Prerenal Failure, Blood Pressure Systolic Increased, Chills, Diarrhoea, Headache, Nausea, Pelvic Fluid Collection
on Jan 21, 2010 Female patient from JAPAN , 62 years of age, was diagnosed with bowel preparation and was treated with Visicol (View Usage). After Visicol was administered, patient had the following side effects: acute prerenal failure, blood pressure systolic increased, chills, diarrhoea, headache (What is headache?), nausea (What is nausea?), pelvic fluid collection. Visicol dosage: Oral. During the same period patient was treated with DIAZEPAM (View Diazepam Review and Diazepam Label ), OLMESARTAN MEDOXIMIL (View Olmesartan Medoximil Review and Olmesartan Medoximil Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), MOSAPRIDE CITRATE (View Mosapride Citrate Review and Mosapride Citrate Label ), TRIMEBUTINE (View Trimebutine Review and Trimebutine Label ), EPERISONE (View Eperisone Review and Eperisone Label ).

6537955-5 | Anaemia, Dyspnoea, Faeces Discoloured, Gastric Ulcer, Nephropathy, Renal Failure Acute
on Jan 08, 2010 Male patient from JAPAN , 77 years of age, was diagnosed with bowel preparation and was treated with Visicol (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, dyspnoea, faeces discoloured, gastric ulcer, nephropathy, renal failure acute. Visicol dosage: (50 Gm),oral. During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), VALSARTAN (View Valsartan Review and Valsartan Label ), BICALUTAMIDE (View Bicalutamide Review and Bicalutamide Label ), TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ). Patient was hospitalized.

6529376-6 | Cold Sweat, Decreased Appetite, Dysgeusia, Pain, Renal Failure Acute
Patient was taking Visicol (View Usage). Patient had the following side effects: cold sweat, decreased appetite, dysgeusia, pain (What is pain?), renal failure acute on Dec 24, 2009 from JAPAN Additional patient health information: Female patient , 78 years of age, was diagnosed with bowel preparation and. Visicol dosage: Oral. During the same period patient was treated with BIODIASTASE 2000 (View Biodiastase 2000 Review and Biodiastase 2000 Label ), REBEMIPIDE (View Rebemipide Review and Rebemipide Label ), TEPRENONE (View Teprenone Review and Teprenone Label ), LOSARTAN POTASSIUM/HCTZ (View Losartan Potassium/hctz Review and Losartan Potassium/hctz Label ), AZELNIDIPINE (View Azelnidipine Review and Azelnidipine Label ), MECOBALAMIN (View Mecobalamin Review and Mecobalamin Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ). Patient was hospitalized.

6526096-9 | Colonic Polyp, Dialysis, Dyspnoea, Renal Failure Acute, Weight Increased
Adverse event was reported on Dec 21, 2009 by a Male patient taking Visicol (View Usage) (Dosage: 50 Gm, Oral) was diagnosed with colonoscopy (What is colonoscopy?) and. Location: JAPAN , 70 years of age, After Visicol was administered, patient had the following side effects: colonic polyp (What is colonic polyp?), dialysis (What is dialysis?), dyspnoea, renal failure acute, weight increased. During the same period patient was treated with PROPOFOL (Intravenous) (View Propofol Review and Propofol Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), PETHIDINE HYDROCHLORIDE (View Pethidine Hydrochloride Review and Pethidine Hydrochloride Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), CARBAZOCHROME SODIUM SULFONATE (View Carbazochrome Sodium Sulfonate Review and Carbazochrome Sodium Sulfonate Label ), TRANEXAMIC ACID (View Tranexamic Acid Review and Tranexamic Acid Label ). Patient was hospitalized.

6526094-5 | Dyspnoea, Oedema, Renal Failure Acute
on Dec 21, 2009 Male patient from JAPAN , 77 years of age, was diagnosed with bowel preparation and was treated with Visicol (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, oedema, renal failure acute. Visicol dosage: 50 Gm, Oral. During the same period patient was treated with AMLODIPINE (View Amlodipine Review and Amlodipine Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), VALSARTAN (View Valsartan Review and Valsartan Label ), BICALUTAMIDE (View Bicalutamide Review and Bicalutamide Label ), TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ). Patient was hospitalized.

6502031-4 | Dialysis, Dyspnoea, Renal Failure Acute, Weight Increased
on Dec 11, 2009 Male patient from JAPAN , 70 years of age, was diagnosed with colonoscopy (What is colonoscopy?), preoperative care and was treated with Visicol (View Usage). Patient had the following side effects: dialysis (What is dialysis?), dyspnoea, renal failure acute, weight increased. Visicol dosage: (50 Gm), Oral. During the same period patient was treated with PROPOFOL (Intravenous) (View Propofol Review and Propofol Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), PETHIDINE HYDROCHLORIDE (View Pethidine Hydrochloride Review and Pethidine Hydrochloride Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), CARBAZOCHROME SODIUM SULFONATE (View Carbazochrome Sodium Sulfonate Review and Carbazochrome Sodium Sulfonate Label ), TRANEXAMIC ACID (View Tranexamic Acid Review and Tranexamic Acid Label ). Patient was hospitalized.

6424747-0 | Feeling Abnormal, Nephrogenic Anaemia, Renal Failure Acute
Patient was taking Visicol (View Usage). After Visicol was administered, patient had the following side effects: feeling abnormal, nephrogenic anaemia, renal failure acute on Oct 26, 2009 from UNITED STATES Additional patient health information: Female patient , 77 years of age, was diagnosed with colonoscopy (What is colonoscopy?), preoperative care and. Visicol dosage: Oral. Patient was hospitalized.

6411216-7 | Dialysis, Haemorrhoids, Heparin-induced Thrombocytopenia, Lip Dry, Nausea, Renal Failure Acute
Adverse event was reported on Oct 16, 2009 by a Male patient taking Visicol (View Usage) (Dosage: (50 Gm) ,oral) was diagnosed with colonoscopy (What is colonoscopy?) and. Location: JAPAN , 64 years of age, Patient experienced the following unwanted or unexpected effects: dialysis (What is dialysis?), haemorrhoids, heparin-induced thrombocytopenia, lip dry, nausea (What is nausea?), renal failure acute. During the same period patient was treated with OLMESARTAN MEDOXOMIL (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ), DOXAZOSIN MESILATE (View Doxazosin Mesilate Review and Doxazosin Mesilate Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), LIDOCAINE (View Lidocaine Review and Lidocaine Label ). Patient was hospitalized.

6394321-3 | Decreased Appetite, Haemorrhoids, Lip Dry, Renal Failure Acute, Volume Blood Decreased
on Oct 02, 2009 Male patient from JAPAN , 64 years of age, was diagnosed with bowel preparation and was treated with Visicol (View Usage). Patient had the following side effects: decreased appetite, haemorrhoids, lip dry, renal failure acute, volume blood decreased. Visicol dosage: (50 Gm) ,oral. During the same period patient was treated with OLMESARTAN MEDOXOMIL (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ), DOXAZOSIN MESILATE (View Doxazosin Mesilate Review and Doxazosin Mesilate Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ). Patient was hospitalized.

6366931-0 | Blood Creatinine Increased, Blood Urea Increased, Dehydration, Hypoaesthesia, Hypocalcaemia, Nephropathy
on Sep 11, 2009 Female patient from JAPAN , 64 years of age, was diagnosed with colonoscopy (What is colonoscopy?) and was treated with Visicol (View Usage). After Visicol was administered, patient had the following side effects: blood creatinine increased, blood urea increased, dehydration, hypoaesthesia, hypocalcaemia, nephropathy. Visicol dosage: 50 Gm, Oral. During the same period patient was treated with ROSUVASTATIN CALCIUM (View Rosuvastatin Calcium Review and Rosuvastatin Calcium Label ), CILOSTAZOL (View Cilostazol Review and Cilostazol Label ), OLMESARTAN MEDOXOMIL (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ), ETIZOLAM (View Etizolam Review and Etizolam Label ). Patient was hospitalized and became disabled.

6354004-2 | Decreased Appetite, Diverticulum Intestinal, Lip Dry, Rectal Polyp, Renal Failure Acute
Patient was taking Visicol (View Usage). Patient experienced the following unwanted or unexpected effects: decreased appetite, diverticulum intestinal, lip dry, rectal polyp, renal failure acute on Sep 04, 2009 from JAPAN Additional patient health information: Male patient , 64 years of age, was diagnosed with colonoscopy (What is colonoscopy?) and. Visicol dosage: (50 Gm), Oral. During the same period patient was treated with OLMESARTAN MEDOXOMIL (View Olmesartan Medoxomil Review and Olmesartan Medoxomil Label ), DOXAZOSIN MESILATE (View Doxazosin Mesilate Review and Doxazosin Mesilate Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ). Patient was hospitalized.

6335374-8 | Anaemia, Decreased Appetite, Malaise, Renal Failure Acute
Adverse event was reported on Aug 25, 2009 by a Female patient taking Visicol (View Usage) (Dosage: 50 Gm, Oral) was diagnosed with colonoscopy (What is colonoscopy?) and. Location: JAPAN , 77 years of age, Patient had the following side effects: anaemia, decreased appetite, malaise, renal failure acute. During the same period patient was treated with SODIUM PICOSULFATE (View Sodium Picosulfate Review and Sodium Picosulfate Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), MEFRUSIDE (View Mefruside Review and Mefruside Label ). Patient was hospitalized.

6317251-1 | Dizziness, Labyrinthitis, Musculoskeletal Pain, Nephrocalcinosis, Nephrolithiasis, Nephropathy, Osteoarthritis, Rotator Cuff Syndrome
on Aug 09, 2009 Male patient from UNITED STATES , 44 years of age, weighting 230.0 lb, was diagnosed with colonoscopy (What is colonoscopy?), hypertension and was treated with Visicol (View Usage). After Visicol was administered, patient had the following side effects: dizziness (What is dizziness?), labyrinthitis, musculoskeletal pain, nephrocalcinosis, nephrolithiasis, nephropathy, osteoarthritis (What is osteoarthritis?), rotator cuff syndrome. Visicol dosage: 48 G Qd, Oral. During the same period patient was treated with MOBIC (View Mobic Review and Mobic Label ), RAMIPRIL (10 Mg Qd, Oral) (View Ramipril Review and Ramipril Label ), PLAVIX (View Plavix Review and Plavix Label ), ZOCOR (View Zocor Review and Zocor Label ), PROBENECID (View Probenecid Review and Probenecid Label ), NORVASC (View Norvasc Review and Norvasc Label ).

6317222-5 | Diabetic Nephropathy, Dialysis, Fat Embolism, Nausea, Nephrocalcinosis, Refusal Of Treatment By Patient, Renal Failure
on Aug 09, 2009 Male patient from UNITED STATES , 65 years of age, weighting 188.0 lb, was diagnosed with colonoscopy (What is colonoscopy?) and was treated with Visicol (View Usage). Patient experienced the following unwanted or unexpected effects: diabetic nephropathy, dialysis (What is dialysis?), fat embolism, nausea (What is nausea?), nephrocalcinosis, refusal of treatment by patient, renal failure. Visicol dosage: 32 Tablets Over 2 Days (once), Oral. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), HUMALOG (View Humalog Review and Humalog Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), ZETIA (View Zetia Review and Zetia Label ). Patient was hospitalized.

6317212-2 | Arteriosclerosis, Intercapillary Glomerulosclerosis, Kidney Fibrosis, Nephrocalcinosis, Pyrexia, Renal Failure Acute, Renal Tubular Atrophy, Urate Nephropathy
Patient was taking Visicol (View Usage). Patient had the following side effects: arteriosclerosis, intercapillary glomerulosclerosis, kidney fibrosis, nephrocalcinosis, pyrexia, renal failure acute, renal tubular atrophy, urate nephropathy on Aug 09, 2009 from UNITED STATES Additional patient health information: Female patient , 67 years of age, was diagnosed with colonoscopy (What is colonoscopy?), preoperative care and. Visicol dosage: Tab/ Once, Oral. During the same period patient was treated with BENAZEPRIL (TABLETS) (View Benazepril (tablets) Review and Benazepril (tablets) Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), LIPITOR (View Lipitor Review and Lipitor Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), METFORMIN (TABLETS) (View Metformin (tablets) Review and Metformin (tablets) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized and became disabled.

6317211-0 | Decreased Appetite, Nephrocalcinosis
Adverse event was reported on Aug 09, 2009 by a Female patient taking Visicol (View Usage) (Dosage: 28 Tablets, Oral) was diagnosed with colonoscopy (What is colonoscopy?) and. Location: UNITED STATES , 60 years of age, weighting 118.2 lb, After Visicol was administered, patient had the following side effects: decreased appetite, nephrocalcinosis. During the same period patient was treated with METOPROLOL (View Metoprolol Review and Metoprolol Label ), LOTREL (View Lotrel Review and Lotrel Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), DETROL (View Detrol Review and Detrol Label ).

6317210-9 | Nephrocalcinosis, Renal Tubular Necrosis
on Aug 09, 2009 Female patient from UNITED STATES , 70 years of age, weighting 115.0 lb, was diagnosed with colonoscopy (What is colonoscopy?) and was treated with Visicol (View Usage). Patient experienced the following unwanted or unexpected effects: nephrocalcinosis, renal tubular necrosis. Visicol dosage: 4 Tabs Every 15 Min For 20 Tabs Total. During the same period patient was treated with LOTREL (View Lotrel Review and Lotrel Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), PROCARDIA (View Procardia Review and Procardia Label ).

6317205-5 | Nephrocalcinosis, Renal Failure Acute
on Aug 09, 2009 Female patient from UNITED STATES , 66 years of age, was diagnosed with colonoscopy (What is colonoscopy?) and was treated with Visicol (View Usage). Patient had the following side effects: nephrocalcinosis, renal failure acute. Visicol dosage: Oral. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

6314853-3 | Convulsion
Patient was taking Visicol (View Usage). After Visicol was administered, patient had the following side effects: convulsion on Aug 17, 2009 from UNITED STATES Additional patient health information: Male patient , 58 years of age, weighting 170.0 lb, was diagnosed with colonoscopy (What is colonoscopy?) and. Visicol dosage: 40 Po. Patient was hospitalized.

6293613-6 | Blood Pressure Decreased, Chills, Gastric Ulcer, Hyperphosphataemia, Hypoaesthesia, Hypocalcaemia, Nephropathy, Renal Failure Acute
Adverse event was reported on Jul 27, 2009 by a Female patient taking Visicol (View Usage) (Dosage: 50 Gm, Oral) was diagnosed with colonoscopy (What is colonoscopy?) and. Location: JAPAN , 86 years of age, Patient experienced the following unwanted or unexpected effects: blood pressure decreased, chills, gastric ulcer, hyperphosphataemia, hypoaesthesia, hypocalcaemia, nephropathy, renal failure acute. During the same period patient was treated with CARVEDILOL (50 Mg, Oral) (View Carvedilol Review and Carvedilol Label ), CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), ECABET (View Ecabet Review and Ecabet Label ), SODIUM ALGINATE (View Sodium Alginate Review and Sodium Alginate Label ), SENNOSIDE (View Sennoside Review and Sennoside Label ), DIMETICONE (View Dimeticone Review and Dimeticone Label ).

6293612-4 | Malaise, Nephrogenic Anaemia, Renal Failure Acute
on Jul 27, 2009 Female patient from JAPAN , 77 years of age, was diagnosed with colonoscopy (What is colonoscopy?), preoperative care and was treated with Visicol (View Usage). Patient had the following side effects: malaise, nephrogenic anaemia, renal failure acute. Visicol dosage: (50 Gm), Oral. During the same period patient was treated with SODIUM PICOSULFATE (View Sodium Picosulfate Review and Sodium Picosulfate Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), MEFRUSIDE (View Mefruside Review and Mefruside Label ). Patient was hospitalized.

6273851-9 | Decreased Appetite, Malaise, Nephrogenic Anaemia, Renal Failure Acute
on Jul 14, 2009 Female patient from JAPAN , 77 years of age, was diagnosed with colonoscopy (What is colonoscopy?), preoperative care and was treated with Visicol (View Usage). After Visicol was administered, patient had the following side effects: decreased appetite, malaise, nephrogenic anaemia, renal failure acute. Visicol dosage: (50 Gm) ,oral. During the same period patient was treated with SODIUM PICOSULFATE (View Sodium Picosulfate Review and Sodium Picosulfate Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), MEFRUSIDE (View Mefruside Review and Mefruside Label ). Patient was hospitalized.

6268082-2 | Carotid Artery Stenosis, Cerebral Infarction
Patient was taking Visicol (View Usage). Patient experienced the following unwanted or unexpected effects: carotid artery stenosis, cerebral infarction on Jul 10, 2009 from JAPAN Additional patient health information: Male patient , 67 years of age, was diagnosed with bowel preparation, colonoscopy (What is colonoscopy?) and. Visicol dosage: (50 Gm), Oral. During the same period patient was treated with FLUNITRAZEPAM (View Flunitrazepam Review and Flunitrazepam Label ), BUTORPHANOL TARTRATE (View Butorphanol Tartrate Review and Butorphanol Tartrate Label ). Patient was hospitalized and became disabled.

6260887-7 | Abdominal Distension, Flatulence, Hypoaesthesia, Vomiting
Adverse event was reported on Jun 19, 2009 by a Female patient taking Visicol (View Usage) (Dosage: 50 Gm, Oral) was diagnosed with bowel preparation, colonoscopy (What is colonoscopy?) and. Location: JAPAN , 69 years of age, Patient had the following side effects: abdominal distension, flatulence, hypoaesthesia, vomiting. During the same period patient was treated with DIFENIDOL HYDROCHLORIDE (View Difenidol Hydrochloride Review and Difenidol Hydrochloride Label ). Patient was hospitalized.

6257749-8 | Anaemia, Decreased Appetite, Malaise, Renal Failure Acute
on Jun 30, 2009 Female patient from JAPAN , 77 years of age, was diagnosed with colonoscopy (What is colonoscopy?) and was treated with Visicol (View Usage). After Visicol was administered, patient had the following side effects: anaemia, decreased appetite, malaise, renal failure acute. Visicol dosage: 50 Gm, Oral. During the same period patient was treated with SODIUM PICOSULFATE (View Sodium Picosulfate Review and Sodium Picosulfate Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ). Patient was hospitalized.

6242085-6 | Cerebral Infarction
on Jun 18, 2009 Male patient from JAPAN , 67 years of age, was diagnosed with colonoscopy (What is colonoscopy?) and was treated with Visicol (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral infarction. Visicol dosage: (50 Gm), Oral. During the same period patient was treated with FLUNITRAZEPAM (View Flunitrazepam Review and Flunitrazepam Label ), BUTORPHANOL TARTRATE (View Butorphanol Tartrate Review and Butorphanol Tartrate Label ). Patient was hospitalized and became disabled.

6237846-3 | Anaemia, Anorexia, Blood Creatinine Increased, Blood Urea Increased, Malaise
Patient was taking Visicol (View Usage). Patient had the following side effects: anaemia, anorexia, blood creatinine increased, blood urea increased, malaise on Jun 15, 2009 from JAPAN Additional patient health information: Female patient , 77 years of age, was diagnosed with bowel preparation, colonoscopy (What is colonoscopy?) and. Visicol dosage: Oral. During the same period patient was treated with SODIUM PICOSULFATE (View Sodium Picosulfate Review and Sodium Picosulfate Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ). Patient was hospitalized.